Trade
Group Sites
Premia
Business Partners
Wealth
FLAME
Property Solutions
IIFL Finance
IIFL MF
IIFL Associates
About IIFl
Contact IIFl
Investor Relations
We're HIRING
FEEDBACK
Register
Login
Sensex
20,286.12
+38.79
0.19%
Nifty
6,187.30
+17.40
0.28%
Commodity Ideas
Stock Ideas
IIFL Live
Customer Service
Corporate News
IIFL
Quote
News
Quotes
View all
MF
View all
Insurance
View all
Commodity
View all
No Result found
Home
Markets
Equities
Market Statistics
Charts
Market Map
Derivatives
Commodity
IPO
Companies
News
Overview
Top
Business
Corporate
Equities
Commodity
Currency
MF
Insurance
IPO
Economy
Global
M&A
Gold
PR Newswire
Dow Jones
Business Wire
Research & Ideas
Overview
Recommendations
Sectors
Market Analysis
Leader Speak
Featured Reports
Sector Indices
Articles
In Focus
Calendar
Economy
Mutual Funds
Fund Snapshot
Fund Houses
Equity Funds
Debt Funds
Balanced Funds
ETFs
NFO Updates
Dividend Tracker
Fund Manager Speak
Apply Online
Discuss
Discussions
Polls
Videos
Chat With Experts
Live TV
Personal Finance
Overview
Insurance
NRI Corner
Loans
Calculators
Articles
RGESS
Union Budget
Railway Budget
Data Monitor
Blog
Portfolio
Company Snapshot
Research
India Infoline Research
MF Investments
FII Investments
Bulk Deals
Block Deals
Daily Share Prices
Monthly Share Prices
Fundamentals
Profit & Loss
Balance Sheet
Cash Flow
Key Ratios
Management
Discussions
Share Holding Pattern
Equity Capital
Structure
Director's Report
Auditor's Report
Quarterly Results
Half Yearly Results
Nine Monthly Results
Annual Results
Background
Key Executives
Board of Directors
Meeting Schedule
Stock history
Company Profile
Products & Services
Raw Materials
Finished Goods
Bankers
Auditors
Location
News
Company News
Sector News
Corporate
Announcements
IndiaInfoline
Markets
Companies
Bafna Pharmaceuticals Ltd
BSE: 532989 | NSE: BAFNAPHARM | ISIN: INE878I01014
Market Cap: [Rs.Cr.] 71 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Indian - Formulations
Discuss this stock
Block Deals
Date
Client Name
Buy/Sell
Qty (Nos.)
Avg.Price
No Block Deals found!
India Infoline Research
Company
|
Sectors
Bafna Mahaveer Chand, Chairman and Managing Director, Bafna Pharmacuticals Limited
Related News
Company
|
Sector
|
Latest
15-May-13
Bafna Pharmaceuticals - Board to consider Dividend
03-May-13
Bafna Pharmaceuticals - Bafna Pharmaceuticals receives product approval for Ghana
23-Apr-13
Bafna Pharmaceuticals to participate iPHEX 2013 in Mumbai
05-Mar-13
Bafna Pharmaceuticals gets registration of RARICAP brand in India
09-Feb-13
Bafna Pharmaceuticals net profit declines 20.34% in the December 2012 quarter
06-Dec-12
Bafna Pharmaceuticals net profit rises 350.00% in the September 2012 quarter
More News
Peer Comparison
Company
Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Ajanta Pharma
2,237.35
22.13
6.28
5.40
27.3
24.2
0.72
Plethico Pharma.
737.10
64.01
1.35
33.34
-5.5
3.8
1.08
Sharon Bio-Med.
364.37
7.07
1.53
9.58
19.1
14.1
1.85
Venus Remedies
350.14
5.76
1.13
3.54
17.7
16.9
0.72
Bliss GVS Pharma
311.36
5.31
1.48
2.15
28.0
42.7
0.04
Parenteral Drugs
288.97
0.00
1.14
58.93
-16.1
-0.7
0.86
Syncom Formul.
261.91
75.29
3.13
13.86
4.3
6.7
0.09
Ahlcon Parent(I)
252.00
19.57
4.66
22.59
12.6
17.0
0.59
Kappac Pharma
246.02
0.00
10.26
0.00
0.0
0.0
0.06
Amrutanjan Healt
203.38
17.30
2.04
9.89
12.6
16.3
0.23
Arvind Remedies
167.12
4.12
1.23
6.60
15.1
16.1
2.12
Zenotech Lab.
109.83
0.00
2.13
0.00
0.0
0.0
0.08
Caplin Point Lab
94.82
6.10
3.13
1.38
29.3
33.1
0.30
Hester Bios
91.70
11.28
1.53
4.56
14.4
20.6
0.35
Combat Drugs
90.76
0.00
15.69
0.00
0.3
0.3
0.07
Prev
Next
Futures & Options Quote
Future
|
Option
Expiry Date
Stock not available in F&O
NA
Instrument:
NA
Expiry Date:
NA
Strike Price:
NA
Open Price:
NA
Average Price:
NA
No. of Contracts Traded:
NA
Open Interest:
NA
Underlying:
NA
Option Type:
NA
Market Lot:
NA
Previous Close:
NA
Day’s High | Low:
NA | NA
Turnover (Cr.):
NA
Open Int. Change:
NA | NA
View detailed F& O quotes >>
Key Information
Key Executives:
Bafna Mahaveer Chand , Chairman & Managing Director
Paras Bafna , Whole-time Director
Sunil Bafna , Director
R Dwarakanathan , Director
Company Head Office / Quarters:
Bafna Towers New No 68,
Old No 299 Thambu Chetty St,
Chennai,
Tamil Nadu-600001
Phone : 91-44-25267517/25270992/4267755
Fax : 91-44-25231264/42677599
E-mail :
cs@bafnapharma.com
Web :
http://www.bafnapharma.com
Registrars:
Cameo Corporate Services Ltd
Subramanian Building
V Floor
1 Club House Road
Chennai - 600 002
Fund Holding
Mutual Funds
|
Fll
Scheme Name
No. of Shares
No data found
Calendar
May-2013
M
T
W
T
F
S
S
13
14
15
16
17
18
19
IPO
Issue Open :
Onesource Techm.
View full month IPO calendar
Economic Events
Fed's Bernanke Delivers Commencement Speech at Bard College
View full month Economic Events calendar
Results
No result today
View full month Results calendar